TissGeneSummary for USP1 |
Gene summary |
Basic gene information | Gene symbol | USP1 |
Gene name | ubiquitin specific peptidase 1 | |
Synonyms | UBP | |
Cytomap | UCSC genome browser: 1p31.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001017415.1, NM_001017416.1,NM_003368.4, | |
Description | deubiquitinating enzyme 1hUBPubiquitin carboxyl terminal hydrolase 1ubiquitin carboxyl-terminal hydrolase 1ubiquitin specific processing protease 1ubiquitin specific protease 1ubiquitin thioesterase 1ubiquitin thiolesterase 1ubiquitin-specific-pro | |
Modification date | 20141207 | |
dbXrefs | MIM : 603478 | |
HGNC : HGNC | ||
Ensembl : ENSG00000162607 | ||
HPRD : 04593 | ||
Vega : OTTHUMG00000008972 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_USP1 | |
BioGPS: 7398 | ||
Pathway | NCI Pathway Interaction Database: USP1 | |
KEGG: USP1 | ||
REACTOME: USP1 | ||
Pathway Commons: USP1 | ||
Context | iHOP: USP1 | |
ligand binding site mutation search in PubMed: USP1 | ||
UCL Cancer Institute: USP1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | BladderTestis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | BLCATGCT | |
Reference showing the relevant tissue of USP1 | ||
Description by TissGene annotations | Cancer gene Have significant anti-correlated miRNA TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006282 | regulation of DNA repair | 18082604 | GO:0009411 | response to UV | 18082604 | GO:0016579 | protein deubiquitination | 18082604 | GO:0006282 | regulation of DNA repair | 18082604 | GO:0009411 | response to UV | 18082604 | GO:0016579 | protein deubiquitination | 18082604 |
Top |
TissGeneExp for USP1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for USP1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
LUAD | hsa-miR-215-5p | MIMAT0000272 | 0.0096 | -0.33 | 60 |
Top |
TissGeneMut for USP1 |
TissGeneSNV for USP1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.N725T | UCEC | 1 |
p.H238D | CESC | 1 |
p.R439C | STAD | 1 |
p.Q454* | HNSC | 1 |
p.S323C | BLCA | 1 |
p.L627F | BRCA | 1 |
p.C506R | LIHC | 1 |
p.E168G | LUAD | 1 |
p.S445G | LIHC | 1 |
p.E744D | BLCA | 1 |
p.M618I | LUSC | 1 |
p.N166K | UCS | 1 |
p.S335L | HNSC | 1 |
p.Y91C | ESCA | 1 |
p.G393R | KIRC | 1 |
p.E234K | SKCM | 1 |
p.Q216* | BRCA | 1 |
p.D199A | UCEC | 1 |
p.Q617* | SKCM | 1 |
p.S292* | LUAD | 1 |
p.A676T | COAD | 1 |
p.S766F | BLCA | 1 |
p.N84D | LUAD | 1 |
p.E221K | LIHC | 1 |
p.E262D | STAD | 1 |
p.K623Q | LIHC | 1 |
p.G667A | LUAD | 1 |
p.S248I | CESC | 1 |
p.L208F | PRAD | 1 |
p.E742G | COAD | 1 |
p.F39L | HNSC | 1 |
p.K224E | BRCA | 1 |
p.K343T | STAD | 1 |
p.F542V | READ | 1 |
p.P777L | CESC | 1 |
p.S475Y | UCEC | 1 |
p.E607G | UCEC | 1 |
p.D502N | SKCM | 1 |
p.D543N | LUAD | 1 |
p.E469Q | BLCA | 1 |
p.K26T | COAD | 1 |
p.E235* | UCEC | 1 |
p.E625K | LGG | 1 |
p.Q297H | SKCM | 1 |
p.Q297H | BLCA | 1 |
p.C506S | BRCA | 1 |
p.N612S | HNSC | 1 |
p.Q212E | LUAD | 1 |
p.E121K | CESC | 1 |
p.P265L | ESCA | 1 |
p.N765K | TGCT | 1 |
p.S605C | LUAD | 1 |
p.S734L | HNSC | 1 |
p.S575R | OV | 1 |
p.K30N | READ | 1 |
p.Q177H | THYM | 1 |
p.K673T | COAD | 1 |
Top |
TissGeneCNV for USP1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for USP1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BG291031 | USP1-USP1 | chr1:62916702 | chr1:62917055 | |
TCGAfusionPortal | PRADA | BRCA | TCGA-AR-A24S-01A | USP1-SGIP1 | Out-of-frame | Chr1:62914337 | Chr1:67091530 |
TCGAfusionPortal | PRADA | PRAD | TCGA-J9-A8CK-01A | USP1-EFCAB7 | 5UTR-CDS | Chr1:62903071 | Chr1:64027380 |
Top |
TissGeneNet for USP1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for USP1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for USP1 |
TissGeneDrug for USP1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for USP1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0015625 | Fanconi Anemia | 5 | BeFree,LHGDN |
umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 5 | BeFree |
umls:C0006142 | Malignant neoplasm of breast | 1 | GAD |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 1 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 1 | BeFree |
umls:C0008626 | Congenital chromosomal disease | 1 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
umls:C0023418 | leukemia | 1 | BeFree |
umls:C0030567 | Parkinson Disease | 1 | BeFree |
umls:C0037286 | Skin Neoplasms | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 1 | BeFree |
umls:C0600139 | Prostate carcinoma | 1 | BeFree |
umls:C0678213 | Complete hydatidiform mole | 1 | BeFree |
umls:C0684249 | Carcinoma of lung | 1 | BeFree |
umls:C0751688 | Malignant Squamous Cell Neoplasm | 1 | BeFree |
umls:C1527249 | Colorectal Cancer | 1 | BeFree |